| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2021-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2023-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1da9877a01befb9bb314b4509c7391d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65586b424972bd23c3429bc2ca6cad88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74c5a128496096d8470d13c8c6f46448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4854a83330f2f4d3e8c7fc8d9fc5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbfb3faf94b17979b517f072a9accc67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a497aed28593b42b22093543146ce593 |
| publicationDate |
2023-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11548897-B2 |
| titleOfInvention |
Crystalline forms of a triazolopyrimidine compound |
| abstract |
Provided herein are crystalline forms of a triazolopyrimidine compound, which is useful for treating a PRC2-mediated disease or disorder. |
| priorityDate |
2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |